Drug Type Small molecule drug |
Synonyms Adapalene-Clindamycin, Adapalene/clindamycin, Clindamycin/adapalene + [2] |
Target |
Mechanism 50S subunit inhibitors(50S ribosomal subunit inhibitors), RARs agonists(Retinoic acid receptors agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date CN (20 Feb 2024), |
Regulation- |
Molecular FormulaC28H28O3 |
InChIKeyLZCDAPDGXCYOEH-UHFFFAOYSA-N |
CAS Registry106685-40-9 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Acne Vulgaris | CN | 20 Feb 2024 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acne Vulgaris | NDA/BLA | CN | 03 Feb 2021 |
Phase 3 | 1,617 | (mmfrgmyekc) = jighpnvzux sjrmwdncrw (hmqwjaussq ) View more | Positive | 01 Nov 2024 | |||
(mmfrgmyekc) = xrtgnlflzz sjrmwdncrw (hmqwjaussq ) View more | |||||||
Phase 3 | 1,617 | kkgbcdxcfe(hmeflejxli) = uyhadbweez qrrylflkdm (rjrmhmcttb ) | Positive | 01 Nov 2024 | |||
Adapalene gel | kkgbcdxcfe(hmeflejxli) = ruajpsenlp qrrylflkdm (rjrmhmcttb ) | ||||||
Phase 3 | 1,617 | Adapalene/Clindamycin(5mg/50mg) | (rkomsmxegj) = fxoavsptil eputsyoloq (gjbqqcbeoe ) Met | Superior | 13 Sep 2021 | ||
Adapalene(0.1%) | (rkomsmxegj) = llnobkhjfs eputsyoloq (gjbqqcbeoe ) Met |